Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(3), P. 890 - 890
Published: March 14, 2023
Despite
recent
therapeutic
advances,
pancreatic
ductal
adenocarcinoma
(PDAC)
remains
one
of
the
most
aggressive
malignancies,
with
remarkable
resistance
to
treatment,
poor
prognosis,
and
clinical
outcome.
More
efficient
approaches
are
urgently
needed
improve
patients’
survival.
Recently,
development
organoid
culture
systems
has
gained
substantial
attention
as
an
emerging
preclinical
research
model.
PDAC
organoids
have
been
developed
study
cancer
biology,
progression,
treatment
response,
filling
translational
gap
between
in
vitro
vivo
models.
Here,
we
review
rapidly
evolving
field
their
potential
powerful
tools
that
could
pave
way
towards
precision
medicine
for
cancer.
Cancers,
Journal Year:
2021,
Volume and Issue:
14(1), P. 190 - 190
Published: Dec. 31, 2021
Today,
innovative
three-dimensional
(3D)
cell
culture
models
have
been
proposed
as
viable
and
biomimetic
alternatives
for
initial
drug
screening,
allowing
the
improvement
of
efficiency
development.
These
are
gaining
popularity,
given
their
ability
to
reproduce
key
aspects
tumor
microenvironment,
concerning
3D
architecture
well
interactions
cells
with
extracellular
matrix
surrounding
non-tumor
cells.
The
development
accurate
may
become
beneficial
decrease
use
laboratory
animals
in
scientific
research,
accordance
European
Union's
regulation
on
3R
rule
(Replacement,
Reduction,
Refinement).
This
review
focuses
impact
cancer
discussing
advantages,
limitations,
compatibility
high-throughput
screenings
automated
systems.
An
insight
is
also
adequacy
available
readouts
interpretation
data
obtained
from
models.
Importantly,
we
emphasize
need
incorporation
additional
complementary
microenvironment
elements
design
models,
towards
improved
predictive
value
efficacy.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2022,
Volume and Issue:
41(1)
Published: Oct. 22, 2022
Cancer-associated
fibroblasts
(CAFs)
are
considered
to
play
a
fundamental
role
in
pancreatic
ductal
adenocarcinoma
(PDAC)
progression
and
chemoresistance.
Patient-derived
organoids
have
demonstrated
great
potential
as
tumor
avatars
for
drug
response
prediction
PDAC,
yet
they
disregard
the
influence
of
stromal
components
on
chemosensitivity.We
established
direct
three-dimensional
(3D)
co-cultures
primary
PDAC
patient-matched
CAFs
investigate
effect
fibroblastic
compartment
sensitivity
gemcitabine,
5-fluorouracil
paclitaxel
treatments
using
an
image-based
assay.
Single-cell
RNA
sequencing
was
performed
three
organoid/CAF
pairs
mono-
co-culture
uncover
transcriptional
changes
induced
by
tumor-stroma
interaction.Upon
with
CAFs,
we
observed
increased
proliferation
reduced
chemotherapy-induced
cell
death
organoids.
data
evidenced
induction
pro-inflammatory
phenotype
co-cultures.
Organoids
showed
expression
genes
associated
epithelial-to-mesenchymal
transition
(EMT)
several
receptor-ligand
interactions
related
EMT
were
identified,
supporting
key
CAF-driven
chemoresistance.Our
results
demonstrate
personalized
models
not
only
profiling
but
also
unraveling
molecular
mechanisms
involved
chemoresistance-supporting
stroma.
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
12(18)
Published: March 14, 2023
Abstract
Decades
of
efforts
in
engineering
vitro
cancer
models
have
advanced
drug
discovery
and
the
insight
into
biology.
However,
establishment
preclinical
that
enable
fully
recapitulating
tumor
microenvironment
remains
challenging
owing
to
its
intrinsic
complexity.
Recent
progress
techniques
has
allowed
development
a
new
generation
can
recreate
complex
vivo
microenvironments
accurately
predict
responses,
including
spheroids,
organoids,
tumor‐on‐a‐chip.
These
biomimetic
3D
are
particular
interest
as
they
pave
way
for
better
understanding
biology
accelerating
anticancer
therapeutics
with
reducing
animal
use.
Here,
recent
advances
developing
these
platforms
modeling
screening,
focusing
on
incorporating
hydrogels
reviewed
reconstitute
physiologically
relevant
microenvironments.
The
combination
spheroids/organoids
microfluidic
technologies
is
also
highlighted
mimic
tumors
discuss
challenges
future
directions
clinical
translation
such
screening
personalized
medicine.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 22, 2024
Abstract
Drug
screening
based
on
in-vitro
primary
tumor
cell
culture
has
demonstrated
potential
in
personalized
cancer
diagnosis.
However,
the
limited
number
of
cells,
especially
from
patients
with
early
stage
cancer,
hindered
widespread
application
this
technique.
Hence,
we
developed
a
digital
microfluidic
system
for
drug
using
cells
and
established
working
protocol
precision
medicine.
Smart
control
logic
was
to
increase
throughput
decrease
its
footprint
parallelly
screen
three
drugs
4
×
cm
2
chip
device
measuring
23
16
3.5
3
.
We
validated
method
an
MDA-MB-231
breast
xenograft
mouse
model
liver
specimens
patients,
demonstrating
suppression
mice/patients
treated
that
were
screened
be
effective
individual
cells.
Mice
on-chip
as
ineffective
exhibited
similar
results
those
groups.
The
identified
through
consistency
absence
mutations
their
related
genes
determined
via
exome
sequencing
tumors,
further
validating
protocol.
Therefore,
technique
may
promote
advances
medicine
treatment
and,
eventually,
any
disease.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: April 20, 2024
Abstract
Cancer
models
play
critical
roles
in
basic
cancer
research
and
precision
medicine.
However,
current
vitro
are
limited
by
their
inability
to
mimic
the
three-dimensional
architecture
heterogeneous
tumor
microenvironments
(TME)
of
vivo
tumors.
Here,
we
develop
an
innovative
patient-specific
lung
assembloid
(LCA)
model
using
droplet
microfluidic
technology
based
on
a
microinjection
strategy.
This
method
enables
precise
manipulation
clinical
microsamples
rapid
generation
LCAs
with
good
intra-batch
consistency
size
cell
composition
evenly
encapsulating
patient
tumor-derived
TME
cells
organoids
inside
microgels.
recapitulate
inter-
intratumoral
heterogeneity,
cellular
diversity,
genomic
transcriptomic
landscape
parental
LCA
could
reconstruct
functional
heterogeneity
cancer-associated
fibroblasts
reflect
influence
drug
responses
compared
organoids.
Notably,
accurately
replicate
outcomes
patients,
suggesting
potential
predict
personalized
treatments.
Collectively,
our
studies
provide
valuable
for
precisely
fabricating
assembloids
promising
Small,
Journal Year:
2022,
Volume and Issue:
18(36)
Published: Feb. 4, 2022
Abstract
The
cell
microenvironment
plays
a
crucial
role
in
regulating
behavior
and
fate
physiological
pathological
processes.
As
the
fundamental
component
of
microenvironment,
extracellular
matrix
(ECM)
typically
possesses
complex
ordered
structures
provides
essential
physical
chemical
cues
to
cells.
Hydrogels
have
attracted
much
attention
recapitulating
ECM.
Compared
natural
synthetic
polymer
hydrogels,
DNA
hydrogels
unique
programmable
capability,
which
endows
material
precise
structural
customization
tunable
properties.
This
review
focuses
on
recent
advances
as
artificial
matrix,
particularly
pure
hydrogels.
It
introduces
classification,
design,
assembly
then
summarizes
state‐of‐the‐art
achievements
encapsulation,
culture,
tissue
engineering
with
Ultimately,
challenges
prospects
for
cellular
applications
are
delivered.